Journal of Artificial Organs

, Volume 14, Issue 1, pp 74–79 | Cite as

A novel counterpulse drive mode of continuous-flow left ventricular assist devices can minimize intracircuit backward flow during pump weaning

  • Masahiko Ando
  • Takashi Nishimura
  • Yoshiaki Takewa
  • Daisuke Ogawa
  • Kenji Yamazaki
  • Koichi Kashiwa
  • Shunei Kyo
  • Minoru Ono
  • Yoshiyuki Taenaka
  • Eisuke Tatsumi
Brief Communication

Abstract

Recent developments in adjunct therapeutic options for end-stage heart failure have enabled us to remove implanted left ventricular assist devices (LVADs) from more patients than before. However, a safe and proper protocol for pump-off trials is yet to be established, because diastolic backward flow in a pump circuit turns up when it is driven at low-flow conditions. We have developed a novel drive mode of centrifugal pumps that can change its rotational speed in synchronization with the cardiac cycle of the native heart. The purpose of this study was to test-drive this novel system of a centrifugal pump in a mock circulation and to evaluate the effect of the counterpulse mode, which increases pump speed just in diastole, on the amount of this nonphysiological intracircuit retrograde flow. A rotary pump (EVAHEART, Sun Medical Technology Research Corporation) was connected to the mock circulation by left ventricular uptake and ascending aortic return. We drove it in the following four conditions: (A) continuous mode at 1500 rpm, (B) counterpulse mode (systolic 1500 rpm, diastolic 2500 rpm), (C) continuous mode at 2000 rpm, and (D) counterpulse mode (systolic 2000 rpm, diastolic 2500 rpm). Data concerning the rotation speed, pump flow, left ventricular pressure, aortic pressure, and pressure head (i.e., aortic pressure-left ventricular pressure) in each condition were collected. After data collection, we analyzed pump flow, and calculated its forward and backward flow. Counterpulse mode decreased the amounts of pump backward flow compared with the continuous mode [mean backward flow, −4, −1, −0.5, 0 l/min, in (A), (B), (C), and (D) conditions, respectively]. The actual amounts of mean backward flow can be different from those in clinical situations; however, this novel drive mode for rotary pumps can relatively decrease pump backward flow during pump weaning and can be beneficial for safe and proper pump-off trials. Further investigations in in vivo settings are currently ongoing.

Keywords

Left ventricular assist device Bridge to recovery Mock circulation 

References

  1. 1.
    Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.PubMedCrossRefGoogle Scholar
  2. 2.
    Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873–84.PubMedCrossRefGoogle Scholar
  3. 3.
    Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from left ventricular assist device in patients with idiopathic dilated cardiomyopathy. Circulation. 2008;118:S94–105.PubMedCrossRefGoogle Scholar
  4. 4.
    Myers TJ, Frazier OH, Mesina HS, Radovancevic B, Gregoric ID. Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant. 2006;25:379–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Yamazaki K, Kihara S, Akimoto T, Tagusari O, Kawai A, Umezu M, Tomioka J, Kormos RL, Griffith BP, Kurosawa H. EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg. 2002;50:461–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Tayama E, Ohashi Y, Niimi Y, Takami Y, Ohtsuka G, Nakata K, Benkowski R, Glueck JA, Nosé Y. The safety system for the rotary blood pump, combination of the valve and LVAD pulsatile mode: in vitro test. Artif Organs. 1998;22:342–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Mano A, Nakatani T, Oda N, Kato T, Niwaya K, Tagusari O, Nakajima H, Funatsu T, Hashimoto S, Komamura K, Hanatani A, Ueda IH, Kitakaze M, Kobayashi J, Yagihara T, Kitamura S. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system? J Heart Lung Transplant. 2008;27:869–74.PubMedCrossRefGoogle Scholar
  8. 8.
    Weber KT, Janicki JS. Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety. Ann Thorac Surg. 1974;17:602–36.PubMedCrossRefGoogle Scholar
  9. 9.
    Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158–62.PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 2011

Authors and Affiliations

  • Masahiko Ando
    • 1
    • 2
  • Takashi Nishimura
    • 3
  • Yoshiaki Takewa
    • 1
  • Daisuke Ogawa
    • 6
  • Kenji Yamazaki
    • 5
  • Koichi Kashiwa
    • 4
  • Shunei Kyo
    • 3
  • Minoru Ono
    • 2
  • Yoshiyuki Taenaka
    • 1
  • Eisuke Tatsumi
    • 1
  1. 1.Department of Artificial OrganNational Cardiovascular Center Research InstituteSuitaJapan
  2. 2.Department of Cardiothoracic SurgeryThe University of TokyoTokyoJapan
  3. 3.Department of Therapeutic Strategy for Heart FailureThe University of TokyoTokyoJapan
  4. 4.Department of Medical EngineeringThe University of Tokyo HospitalTokyoJapan
  5. 5.Department of Cardiovascular SurgeryTokyo Women’s Medical UniversityTokyoJapan
  6. 6.Sun Medical Technology Research CorporationSuwaJapan

Personalised recommendations